A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia

The study was designed to compare clofarabine plus daunorubicin vs daunorubicin/ara-C in older patients with acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS). Eight hundred and six untreated patients in the UK NCRI AML16 trial with AML/high-risk MDS (median age, 67 years; ra...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Leukemia
Hoofdauteurs: Burnett, A K, Russell, N H, Hills, R K, Kell, J, Nielsen, O J, Dennis, M, Cahalin, P, Pocock, C, Ali, S, Burns, S, Freeman, S, Milligan, D, Clark, R E
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292678/
https://ncbi.nlm.nih.gov/pubmed/27624670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.225
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items